Equivalent uniform RBE-weighted dose in eye plaque brachytherapy

被引:2
|
作者
Chvetsov, Alexei V. [1 ,2 ]
机构
[1] Univ Washington, Dept Radiat Oncol, Seattle, WA USA
[2] Univ Washington, Dept Radiat Oncol, 1959 NE Pacific St, Seattle, WA 98004 USA
关键词
BED; EUD; eye plaque brachytherapy; LQ model; RBE; UVEAL MELANOMA; I-125; RADIOBIOLOGY; DOSIMETRY; AAPM;
D O I
10.1002/mp.16982
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundBrachytherapy for ocular melanoma is based on the application of eye plaques with different spatial dose nonuniformity, time-dependent dose rates and relative biological effectiveness (RBE). PurposeWe propose a parameter called the equivalent uniform RBE-weighted dose (EUDRBE) that can be used for quantitative characterization of integrated cell survival in radiotherapy modalities with the variable RBE, dose nonuniformity and dose rate. The EUDRBE is applied to brachytherapy with 125I eye plaques designed by the Collaborative Ocular Melanoma Study (COMS). MethodsThe EUDRBE is defined as the uniform dose distribution with RBE = 1 that causes equal cell survival for a given nonuniform dose distribution with the variable RBE > 1. The EUDRBE can be used for comparison of cell survival for nonuniform dose distributions with different RBE, because they are compared to the reference dose with RBE = 1. The EUDRBE is applied to brachytherapy with 125I COMS eye plaques that are characterized by a steep dose gradient in tumor base-apex direction, protracted irradiation during time intervals of 3-8 days, and variable dose-rate dependent RBE with a maximum of about 1.4. The simulations are based on dose of 85 Gy prescribed to the farthest intraocular extent of the tumor (tumor apex). To compute the EUDRBE in eye plaque brachytherapy and correct for protracted irradiation, the distributions of physical dose have been converted to non-uniform distributions of biologically effective dose (BED) to include the biological effects of sublethal cellular repair, Our radiobiological analysis considers the combined effects of different time-dependent dose rates, spatial dose non-uniformity, dose fractionation and different RBE and can be used to derive optimized dose regimens brachytherapy. ResultsOur simulations show that the EUDRBE increases with the prescription depths and the maximum increase may achieve 6% for the tumor height of 12 mm. This effect stems from a steep dose gradient within the tumor that increases with the prescription depth. The simulations also show that the EUDRBE increase may achieve 12% with increasing the dose rate when implant duration decreases. The combined effect of dose nonuniformity and dose rate may change the EUDRBE up to 18% for the same dose prescription of 85 Gy to tumor apex. The absolute dose range of 48-61 Gy (RBE) for the EUDRBE computed using 4 or 5 fractions is comparable to the dose prescriptions used in stereotactic body radiation therapy (SBRT) with megavoltage X-rays (RBE = 1) for different cancers. The tumor control probabilities in SBRT and eye plaque brachytherapy are very similar at the level of 80% or higher that support the hypothesis that the selected approximations for the EUDRBE are valid. ConclusionsThe computed range of the EUDRBE in 125I COMS eye plaque brachytherapy suggests that the selected models and hypotheses are acceptable. The EUDRBE can be useful for analysis of treatment outcomes and comparison of different dose regimens in eye plaque brachytherapy.
引用
收藏
页码:3093 / 3100
页数:8
相关论文
共 50 条
  • [41] RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy
    Liu, Chunbo
    Bradley, Julie A.
    Zheng, Dandan
    Vega, Raymond B. Mailhot
    Beltran, Chris J.
    Mendenhall, Nancy
    Liang, Xiaoying
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (04):
  • [42] COMPARISON OF THE BIOLOGICALLY EFFECTIVE UNIFORM DOSE, EQUIVALENT UNIFORM DOSE, EFFECTIVE DOSE AND GENERALIZED EQUIVALENT UNIFORM DOSE CONCEPTS
    Mavroidis, P.
    Papanikolaou, N.
    Lind, B.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S239 - S240
  • [43] Variation of RBE with dose and dose rate for a miniature electronic brachytherapy source
    Fowler, J
    Dale, R
    Rusch, T
    MEDICAL PHYSICS, 2004, 31 (06) : 1927 - 1927
  • [44] Hypoxia-informed RBE-weighted beam orientation optimization for intensity modulated proton therapy
    Ramesh, Pavitra
    Ruan, Dan
    Liu, S. John
    Seo, Youngho
    Braunstein, Steve
    Sheng, Ke
    MEDICAL PHYSICS, 2024, 51 (03) : 2320 - 2333
  • [45] Seed localization in eye plaque brachytherapy
    Emery, RS
    Szechter, A
    MEDICAL PHYSICS, 1998, 25 (08) : 1491 - 1492
  • [46] Process Mapping of Eye Plaque Brachytherapy
    Huynh, J.
    Kim, Y.
    MEDICAL PHYSICS, 2015, 42 (06) : 3482 - 3482
  • [47] Tumor Control Probability for Non-Small Cell Lung Cancer Treated with Proton Therapy: Constant vs Variable RBE-Weighted Dose
    Peeler, C.
    Titt, U.
    Mohan, R.
    Liao, Z.
    Mirkovic, D.
    MEDICAL PHYSICS, 2019, 46 (06) : E587 - E587
  • [48] Treating Ocular Melanoma with Eye Plaque Brachytherapy: COMS Or NAG Eye Plaque?
    Zhang, H.
    Martin, D.
    Davidorf, F.
    Qi, Y.
    MEDICAL PHYSICS, 2009, 36 (06) : 2773 - +
  • [49] RBE-Weighted Dose Calculation Based On Dual-Layer Spectral CT in Carbon Ion Therapy with Monte Carlo Simulation Using TOPAS
    Yoon, E.
    Shin, W.
    Kim, B.
    Son, J.
    Choi, C.
    Kim, J.
    Jung, S.
    Park, J.
    MEDICAL PHYSICS, 2022, 49 (06) : E856 - E857
  • [50] RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma
    Wang, Weiwei
    Huang, Zhijie
    Sheng, Yinxiangzi
    Zhao, Jingfang
    Shahnazi, Kambiz
    Zhang, Qing
    Jiang, Guoliang
    RADIOTHERAPY AND ONCOLOGY, 2020, 144 : 30 - 36